CA9 expression, an intrinsic cellular marker for hypoxia, has been suggested to correlate with poor survival in high-grade STS [51], and GLUT1 expression and enhanced glucose metabolism in STS have been linked to proliferative activity and tumor grade [52-55]. This evidence concerns the gene SLC2A1 and telomere syndrome.